Drug & medication recalls Moderate risk

EPHEDrine 25 mg/ in 0 recalled over sterility concerns

Recall date
December 17, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
SCA Pharmaceuticals recalls ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals 8521 Kno…
Recall number
D-0213-2021
FDA classification
Class II
Brand / firm
SCA Pharmaceuticals
Sold / distributed
Product was distributed to hospitals nationwide.

Why it was recalled

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals 8521 Knoedl Ct., Little Rock, AR, 72205, barcode 70004060409

Get recall alerts

Free email alert whenever SCA Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: SCA Pharmaceuticals